Leaflet ORSERDU 86mg film-coated tablets
Indicated for: breast cancer
Route of administration: oral
Substance: elacestrant (antineoplastic agent)
ATC: L02BA04 (Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-estrogens)
This medicine may affect fertility.
Dose adjustment may be needed in liver disease.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Elacestrant is a medication used in the treatment of certain types of breast cancer, especially in postmenopausal women with hormone receptor-positive tumors. This medicine works by blocking estrogen receptors, thereby reducing the stimulation of hormone-dependent cancer cells. Elacestrant may be recommended when other hormonal therapies are no longer effective.
Elacestrant is usually administered as tablets, according to the oncologist’s instructions. The dose and duration of treatment are determined individually, based on the patient’s general condition and response to therapy. It is important to take the medication regularly and not to stop treatment without medical advice.
Side effects may include nausea, fatigue, headaches, hot flashes, or digestive disturbances. In some cases, changes in blood test results or allergic reactions may occur. If unusual or severe symptoms appear, it is recommended to contact your doctor immediately.
Elacestrant provides an additional option for patients with advanced breast cancer, helping to slow disease progression. Careful monitoring and constant communication with the medical team are essential for the safety and effectiveness of the treatment.
General data about ORSERDU 86mg
- Substance: elacestrant
- Date of latest medicines list: 01-06-2026
- Product code: W71459001
- Concentration: 86mg
- Pharmaceutical form: film-coated tablets
- Quantity: 28
- Product type: Generic medicine
- Price: 14474.80 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for elacestrant
- 345mg
- 86mg